Articles tagged with #obesity-treatment
Eli Lilly's new drug retatrutide is making waves in the medical community as it clears its first late-stage trial for diabetes. This milestone places retatrutide at the forefront of obesity treatment advancements. With obesity rates surging globally, this development could transform patient care and pharmaceutical strategies.
